SUBOXONE
SUBOXONE
Approved
DIN Number
02468085
Drug Class
Human
Market Date
Feb 14, 2018
Company
HC
INDIVIOR UK LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02468085
AIG Number0252216003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N07BC51 BUPRENORPHINE, COMBINATIONS
Product Specifications
Dosage FormTablet
Route of AdministrationSublingual
AHFS Classification28:10.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)Active
Strength: 12 MG
Monograph: BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)
NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)Active
Strength: 3 MG
Monograph: NALOXONE (NALOXONE HYDROCHLORIDE DIHYDRATE)